GI tract

Artificial FMT manufacturing will help scale up treatment of gut disorders

The human stool bank set up to facilitate faecal microbiota transplants (FMT) is now developing artificial ‘super stool’ manufacturing capacity to widen access to treatment for conditions such as C. difficile . Set up by South Australian gastroenterologists Dr Sam Costello and Dr Rob Bryant, BiomeBank is now working in collaboration with bio-engineers at RMIT ...

Already a member?

Login to keep reading.

© 2021 the limbic